Stock Information
Septerna Inc (SEPN)
Ticker Symbol: SEPN
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,127.41 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.1129
Revenue (TTM): $1.03 M
Dividend Yield: N/A%
ROE: -12.63%
Latest News
-
HC Wainwright & Co. Reiterates Buy on Septerna, Maintains $40 Price Target
Tue, Apr 14, 2026 7:13 AM
-
Septerna, Inc. Announces Initiation of Phase 1 Trial for Oral PTH1R Agonist SEP-479 in Hypoparathyroidism
Mon, Apr 13, 2026 9:20 AM
-
Septerna Doses First Participants In Phase 1 Trial Of SEP-479 For Hypoparathyroidism
Mon, Apr 13, 2026 8:07 AM
-
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
Mon, Apr 13, 2026 8:00 AM
Key Financials
Financial data not available
